Neol Biosolutions, S.A. announced that it will receive an equity round of funding from Dimension 14, a fund managed by individual investor, Salvador Ortí on January 30, 2019. Post-closing of the transaction, the investor will hold majority stake in the company. The transaction requires approval from shareholders of the company.